Susan Loring

Array ( [id] => 3525439 [patent_doc_number] => 05541101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Anti-oxytocin receptor antibodies' [patent_app_type] => 1 [patent_app_number] => 8/101041 [patent_app_country] => US [patent_app_date] => 1993-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6849 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541101.pdf [firstpage_image] =>[orig_patent_app_number] => 101041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3535475 [patent_doc_number] => 05494670 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Method of treating ketosis' [patent_app_type] => 1 [patent_app_number] => 8/095613 [patent_app_country] => US [patent_app_date] => 1993-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3933 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494670.pdf [firstpage_image] =>[orig_patent_app_number] => 095613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725128 [patent_doc_number] => 05672688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Immunoglobulin F.sub.c fragment bound to an alkylating, antibiotic, or antimetabolic antitum or substance' [patent_app_type] => 1 [patent_app_number] => 8/093885 [patent_app_country] => US [patent_app_date] => 1993-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2606 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672688.pdf [firstpage_image] =>[orig_patent_app_number] => 093885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3026500 [patent_doc_number] => 05348880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-20 [patent_title] => 'Tumor associated monoclonal antibody 81AV/78' [patent_app_type] => 1 [patent_app_number] => 8/094589 [patent_app_country] => US [patent_app_date] => 1993-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6114 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/348/05348880.pdf [firstpage_image] =>[orig_patent_app_number] => 094589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3457763 [patent_doc_number] => 05468468 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-21 [patent_title] => 'Method for making a monoclonal antibody, monoclonal antibodies to .alpha. P D' [patent_app_type] => 1 [patent_app_number] => 8/081216 [patent_app_country] => US [patent_app_date] => 1993-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8722 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/468/05468468.pdf [firstpage_image] =>[orig_patent_app_number] => 081216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3541621 [patent_doc_number] => 05480974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'Antibodies to human C5a receptor' [patent_app_type] => 1 [patent_app_number] => 8/079051 [patent_app_country] => US [patent_app_date] => 1993-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 11766 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480974.pdf [firstpage_image] =>[orig_patent_app_number] => 079051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3555495 [patent_doc_number] => 05519120 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Urokinase-type plasminogen activator receptor antibodies' [patent_app_type] => 1 [patent_app_number] => 8/085122 [patent_app_country] => US [patent_app_date] => 1993-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 61 [patent_no_of_words] => 51073 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 567 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/519/05519120.pdf [firstpage_image] =>[orig_patent_app_number] => 085122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3523346 [patent_doc_number] => 05527685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Antibodies to macrophage stimulating protein, bioassay and immunopurification method' [patent_app_type] => 1 [patent_app_number] => 8/076880 [patent_app_country] => US [patent_app_date] => 1993-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 3192 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527685.pdf [firstpage_image] =>[orig_patent_app_number] => 076880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456459 [patent_doc_number] => 05378812 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Monoclonal antibodies cross-reactive and cross-protective against P. aeruginosa serotypes' [patent_app_type] => 1 [patent_app_number] => 8/066604 [patent_app_country] => US [patent_app_date] => 1993-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12371 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378812.pdf [firstpage_image] =>[orig_patent_app_number] => 066604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3409588 [patent_doc_number] => 05443827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Fibrin-targeted inhibitors of thrombin' [patent_app_type] => 1 [patent_app_number] => 8/058699 [patent_app_country] => US [patent_app_date] => 1993-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 9288 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443827.pdf [firstpage_image] =>[orig_patent_app_number] => 058699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3471858 [patent_doc_number] => 05476784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Gonococcal anti-idiotypic antibodies and methods and compositions using them' [patent_app_type] => 1 [patent_app_number] => 8/043663 [patent_app_country] => US [patent_app_date] => 1993-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 28 [patent_no_of_words] => 18633 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476784.pdf [firstpage_image] =>[orig_patent_app_number] => 043663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591003 [patent_doc_number] => 05521085 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-28 [patent_title] => 'Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes' [patent_app_type] => 1 [patent_app_number] => 8/041244 [patent_app_country] => US [patent_app_date] => 1993-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 38610 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/521/05521085.pdf [firstpage_image] =>[orig_patent_app_number] => 041244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3425856 [patent_doc_number] => 05459235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-17 [patent_title] => 'Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils' [patent_app_type] => 1 [patent_app_number] => 8/033873 [patent_app_country] => US [patent_app_date] => 1993-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 48 [patent_no_of_words] => 12491 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/459/05459235.pdf [firstpage_image] =>[orig_patent_app_number] => 033873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781115 [patent_doc_number] => 05840297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process' [patent_app_type] => 1 [patent_app_number] => 8/034572 [patent_app_country] => US [patent_app_date] => 1993-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 19450 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840297.pdf [firstpage_image] =>[orig_patent_app_number] => 034572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3409773 [patent_doc_number] => 05437995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-01 [patent_title] => 'Monoclonal antibody against an acidic FGF protein and hybridoma for its production' [patent_app_type] => 1 [patent_app_number] => 8/026257 [patent_app_country] => US [patent_app_date] => 1993-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 12800 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/437/05437995.pdf [firstpage_image] =>[orig_patent_app_number] => 026257 [rel_patent_id] =>[rel_patent_doc_number] =>)